| Transancestral mapping and genetic load in systemic lupus erythematosus CD Langefeld, HC Ainsworth, DSC Graham, JA Kelly, ME Comeau, ... Nature communications 8 (1), 16021, 2017 | 349 | 2017 |
| Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18 BR Lauwerys, N Garot, JC Renauld, FA Houssiau The Journal of Immunology 165 (4), 1847-1853, 2000 | 260 | 2000 |
| Synovial tissue research: a state-of-the-art review C Orr, E Vieira-Sousa, DL Boyle, MH Buch, CD Buckley, JD Cañete, ... Nature Reviews Rheumatology 13 (8), 463-475, 2017 | 258 | 2017 |
| The anti‐CD20 antibody rituximab reduces the Th17 cell response FL van de Veerdonk, B Lauwerys, RJ Marijnissen, K Timmermans, ... Arthritis & Rheumatism 63 (6), 1507-1516, 2011 | 235 | 2011 |
| Identification of distinct gene expression profiles in the synovium of patients with systemic lupus erythematosus AN Toukap, C Galant, I Theate, AL Maudoux, RJU Lories, FA Houssiau, ... Arthritis & Rheumatism 56 (5), 1579-1588, 2007 | 230 | 2007 |
| Juvenile-onset systemic lupus erythematosus: different clinical and serological pattern than adult-onset systemic lupus erythematosus IEA Hoffman, BR Lauwerys, F De Keyser, TWJ Huizinga, D Isenberg, ... Annals of the rheumatic diseases 68 (3), 412-415, 2009 | 217 | 2009 |
| Rituximab versus tocilizumab in anti-TNF inadequate responder patients with rheumatoid arthritis (R4RA): 16-week outcomes of a stratified, biopsy-driven, multicentre, open … F Humby, P Durez, MH Buch, MJ Lewis, H Rizvi, F Rivellese, A Nerviani, ... The Lancet 397 (10271), 305-317, 2021 | 210 | 2021 |
| Synergistic proliferation and activation of natural killer cells by interleukin 12 and interleukin 18 BR Lauwerys, JC Renauld, FA Houssiau Cytokine 11 (11), 822-830, 1999 | 198 | 1999 |
| Down‐regulation of interferon signature in systemic lupus erythematosus patients by active immunization with interferon α–kinoid BR Lauwerys, E Hachulla, F Spertini, E Lazaro, C Jorgensen, X Mariette, ... Arthritis & Rheumatism 65 (2), 447-456, 2013 | 187 | 2013 |
| A proteinuria cut-off level of 0.7 g/day after 12 months of treatment best predicts long-term renal outcome in lupus nephritis: data from the MAINTAIN Nephritis Trial F Tamirou, BR Lauwerys, M Dall'Era, M Mackay, B Rovin, R Cervera, ... Lupus science & medicine 2 (1), e000123, 2015 | 181 | 2015 |
| Genetic association of miRNA-146a with systemic lupus erythematosus in Europeans through decreased expression of the gene SE Löfgren, J Frostegård, L Truedsson, BA Pons-Estel, S D'Alfonso, ... Genes & Immunity 13 (3), 268-274, 2012 | 168 | 2012 |
| Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab … P Durez, J Malghem, AN Toukap, G Depresseux, BR Lauwerys, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2007 | 160 | 2007 |
| Type I interferon blockade in systemic lupus erythematosus: where do we stand? BR Lauwerys, J Ducreux, FA Houssiau Rheumatology 53 (8), 1369-1376, 2014 | 136 | 2014 |
| Regulatory polymorphisms modulate the expression of HLA class II molecules and promote autoimmunity P Raj, E Rai, R Song, S Khan, BE Wakeland, K Viswanathan, C Arana, ... elife 5, e12089, 2016 | 129 | 2016 |
| Gene expression profiling in the synovium identifies a predictive signature of absence of response to adalimumab therapy in rheumatoid arthritis V Badot, C Galant, A Nzeusseu Toukap, I Theate, AL Maudoux, ... Arthritis research & therapy 11, 1-13, 2009 | 126 | 2009 |
| Side-effects of intravenous cyclophosphamide pulse therapy F Martin, B Lauwerys, C Lefebvre, JP Devogelaer, FA Houssiau Lupus 6 (3), 254-257, 1997 | 125 | 1997 |
| Integrative analysis reveals a molecular stratification of systemic autoimmune diseases G Barturen, S Babaei, F Català‐Moll, M Martínez‐Bueno, Z Makowska, ... Arthritis & rheumatology 73 (6), 1073-1085, 2021 | 119 | 2021 |
| Efficacy of anti-IL-1 treatment in familial Mediterranean fever: a systematic review of the literature JCH van der Hilst, M Moutschen, PE Messiaen, BR Lauwerys, ... Biologics: Targets and Therapy, 75-80, 2016 | 117 | 2016 |
| Subcutaneous golimumab for children with active polyarticular-course juvenile idiopathic arthritis: results of a multicentre, double-blind, randomised-withdrawal trial HI Brunner, N Ruperto, N Tzaribachev, G Horneff, VG Chasnyk, ... Annals of the rheumatic diseases 77 (1), 21-29, 2018 | 113 | 2018 |
| Rate and clinical presentation of macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis treated with canakinumab AA Grom, NT Ilowite, V Pascual, HI Brunner, A Martini, D Lovell, ... Arthritis & Rheumatology 68 (1), 218-228, 2016 | 109 | 2016 |
